Able Biolabs
PrivateLast Round
Accelerator
Apr 1, 2024
Momentum Score
25 /100
Company Overview
Able Biolabs is a drug discovery company that provides preclinical and clinical R&D services for clients in the biotech and consumer goods industries.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Able Biolabs Comps
Public and private peers based on sector, stage, and business model.
Able Biolabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 1, 2024 |
Able Biolabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biostack Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Monthly visitors grew 688% MoM, reaching 5K.
- Aug 26, 2025
Grew 100% QoQ, from 3 to 6 employees.
Able Biolabs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Able Biolabs's valuation, stock price, and market status.
